Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Duloxetine Hydrochloride

Client Email

Product

Duloxetine Hydrochloride
CAS 116539-55-0
CAS 321-38-0
US Patents

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Contact Supplier

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Evonik

Contact Supplier

Gensenta is a trusted CDMO partner with robust history, commitment to quality, innovative mindset and commitment to sustainability.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Duloxetine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

109 API Suppliers, 45 USDMF, 28 CEP/COS, 13 JDMF, 19 EU WC, 26 KDMF, 18 NDC API, 59 Listed Suppliers, $ API Reference Price

109 API Suppliers
45 USDMF
28 CEP/COS
13 JDMF
19 EU WC
26 KDMF
18 NDC API
59 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

29 API Suppliers

29 API Suppliers

FINISHED DOSAGE FORMULATIONS

583 FDF Dossiers, 98 FDA Orange Book, 282 Europe, 44 Canada, 14 Australia, 30 South Africa, 115 Listed Dossiers

583 FDF Dossiers
98 FDA Orange Book
282 Europe
44 Canada
14 Australia
30 South Africa
115 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 15 DKSH, 2 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 6 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 40 Controlled & Modified Release, 40 Direct Compression, 35 Solubilizers, 32 Disintegrants & Superdisintegrants, 25 Granulation, 25 Thickeners and Stabilizers, 20 Parenteral, 20 Taste Masking, 20 Topical, 17 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 9 Empty Capsules, 8 API Stability Enhancers, 8 Emulsifying Agents, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers

86 Fillers, Diluents & Binders
73 Coating Systems & Additives
40 Controlled & Modified Release
40 Direct Compression
35 Solubilizers
32 Disintegrants & Superdisintegrants
25 Granulation
25 Thickeners and Stabilizers
20 Parenteral
20 Taste Masking
20 Topical
17 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Film Formers & Plasticizers
16 Co-Processed Excipients
9 Empty Capsules
8 API Stability Enhancers
8 Emulsifying Agents
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
4 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 216 Finished Drug Prices, 14 Annual Reports

2 US Medicaid Prescriptions
216 Finished Drug Prices
14 Annual Reports

MARKET PLACE

23 APIs, 7 FDF Dossiers

23 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 6 Health Canada Patents

16 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 10 Others

3 EDQM
3 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

2 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 231 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

16 All

01 16SUN PHARM

filter Patent Number Reset all filters

16 All

01 49839626

02 410413525

03 410959982

04 411202772

filter API Patent Reset all filters

16 All

01 16Blank

filter FDF Patent Reset all filters

16 All

01 16Y

filter Expiration Date Reset all filters

16 All

01 162037-04-13

US Patents
Health Canada Patents

Product Main Page

01

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioJapan 2024

Not Confirmed

SUN PHARM

BioJapan 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 10959982

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioJapan 2024

Not Confirmed

SUN PHARM

BioJapan 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioJapan 2024

Not Confirmed

SUN PHARM

BioJapan 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 11202772

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SUN PHARM

DULOXETINE HYDROCHLORIDE

BioJapan 2024

Not Confirmed

SUN PHARM

BioJapan 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-04-13

DULOXETINE HYDROCHLORIDE

US Patent Number : 9839626

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212516

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-13